title: The role of the reporting framework MIATA within current efforts to advance immune monitoring.
authors.affiliation: ZellNet Consulting, Inc., 555 North Avenue, Suite 25-S, Fort Lee, NJ 07024, USA. Electronic address: sylvia@zellnet.com.
authors.forename: Sylvia
authors.initials: S
authors.lastname: Janetzki
authors.affiliation: TRON - Translational Oncology at the University Medical Center of the Johannes Gutenberg-University Mainz gGmbH, Verfügungsgebäude 708, Langenbeckstr. 1, 55131 Mainz, Germany.
authors.forename: Cedrik M
authors.initials: CM
authors.lastname: Britten
mesh_terms: D032921:Consensus; D003299:Cooperative Behavior; D019983:Guideline Adherence / Q000592:standards; D006801:Humans; D007159:Immunologic Tests / Q000592:standards*; D007167:Immunotherapy / Q000379:methods*; D007391:International Cooperation; D007753:Laboratories / Q000592:standards*; D059021:Laboratory Proficiency Testing / Q000592:standards*; D015166:Monitoring, Immunologic / Q000592:standards*; D015588:Observer Variation; D017410:Practice Guidelines as Topic / Q000592:standards; D011237:Predictive Value of Tests; D011786:Quality Control; D015203:Reproducibility of Results; D013601:T-Lymphocytes / Q000276:immunology*; D016896:Treatment Outcome
keywords: Immune assays; Immune monitoring; MIATA; Reporting